Eur Rev Med Pharmacol Sci 2014; 18 (24): 3735-3736

Attention to Infliximab adverse events: chimeric monoclonal antibodies can induce anti chimeric antibodies that may result in Kounis hypersensitivity associated acute coronary syndrome

N.G. Kounis, G.N. Kounis, G.D. Soufras, G. Tsigkas, G. Hahalis

Department of Medical Sciences, Northwestern Greece Highest Institute of Education and Technology, Patras, Achaia, Greece. ngkounis@otenet.gr

Free PDF Download

To cite this article

N.G. Kounis, G.N. Kounis, G.D. Soufras, G. Tsigkas, G. Hahalis
Attention to Infliximab adverse events: chimeric monoclonal antibodies can induce anti chimeric antibodies that may result in Kounis hypersensitivity associated acute coronary syndrome

Eur Rev Med Pharmacol Sci
Year: 2014
Vol. 18 - N. 24
Pages: 3735-3736

Keywords Related articles:

  1. Infliximab in inflammatory bowel disease: attention to adverse events
  2. Evaluation of echocardiographic indices for the prediction of major adverse events during long-term follow-up in chronic hemodialysis patients with normal left ventricular ejection fraction
  3. Screening of genes related to acute coronary syndrome and identification of functional modules in the PPI network
  4. Predictive value of umbilical artery Doppler for adverse perinatal outcome in patients with HELLP syndrome
  5. The relationship between antibeta 2 glycoprotein antibodies and SYNTAX score in patients undergoing coronary artery by-pass graft surgery